GLOW Blend — tissue repair meets collagen support.
GLOW Blend builds on the Wolverine combination by adding GHK-Cu, a copper-binding tripeptide studied for its effect on collagen synthesis and tissue remodelling. The result is a single 70mg vial containing three peptides: GHK-Cu (50mg), BPC-157 (10mg) and TB-500 (10mg) — a ratio that has become the de-facto standard across the EU suppliers that carry it.
What GHK-Cu adds to the mix
GHK-Cu (copper tripeptide-1) was first isolated from human plasma by Dr. Loren Pickart in the 1970s. It is studied for stimulating collagen and glycosaminoglycan synthesis in dermal fibroblasts, modulating matrix metalloproteinases for organised tissue remodelling, and broad antioxidant activity. Combined with BPC-157 and TB-500, the blend is positioned by suppliers for research spanning both soft-tissue repair and skin/collagen-quality questions — broader than the Wolverine combination alone.
Naming note: "GLOW80" vs "GLOW70"
Almost every EU and international supplier that stocks this blend lists it as 70mg total. One supplier markets the identical 50/10/10mg formula under the name "GLOW80" — its own Certificate of Analysis confirms the contents match the standard 70mg recipe, so the "80" appears to be a branding choice rather than a different formulation. PeptideCompare lists this product under the 70mg size to keep comparisons consistent across vendors.
Compare GLOW Blend prices across EU suppliers
70mg vials · COA-verified EU vendors